Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
EBOS Group Limited ( (AU:EBO) ) has provided an update.
EBOS Group Limited has announced the completion of its retail offer, raising up to A$50 million (NZ$54 million), with new shares issued at NZ$36.65 or A$33.92. The new shares will be traded on the NZX and ASX starting 13 and 14 May 2025, respectively, and will rank equally with existing shares. This move is expected to strengthen EBOS’s market position and provide additional capital for its operations, benefiting stakeholders by potentially enhancing the company’s growth and market reach.
More about EBOS Group Limited
EBOS Group Limited is the largest and most diversified marketer, wholesaler, and distributor of healthcare, medical, and pharmaceutical products in Australasia. It is also a leading brand owner, product marketer, and distributor in the animal care sector.
Average Trading Volume: 60,324
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$7.04B
For a thorough assessment of EBO stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue